Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
Early-Career Opportunities
IASLC Academy
Publications, Resources & Guidelines
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 1 - 12 items out of 1999 results
Landing page
Call for Nominations for the 2023 IASLC Board of Directors Election Open Now Through January 25, 2023
Podcast
Lung Cancer Considered Introduces New Podcast Hosts
Podcast
Women In Thoracic Oncology
Press release
Selected Gene mRNA Expression Is Not Predictive of Improved Overall Survival Among Patients Undergoing Surgery for Stage II-III Lung Cancer
Press release
Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations
Press release
Adding Ipilimumab to Pembrolizumab Does Not Improve Efficacy in patients with NSCLC
Press release
LCMC3: Neoadjuvant Atezolizumab Safe, Meets Primary Endpoint of Pathologic Response Rate Prior to Lung Cancer Surgery
Press release
Nivolumab Effective Treatment for Malignant Mesothelioma
Press release
TALENT Study Supports NLCST and NELSON Trial Results
Landing page
World Conference on Lung Cancer 2020 News
Landing page
Donate
Landing page
Journals
Pagination
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page